BMS's Abecma Faces J&J Threat Despite Pivotal Success In Earlier Myeloma Setting

Both Rivals Tout Blockbuster Potential

Myeloma multiplex leukemia cancer 3d color render illustration isometric view
More Than 35,000 New Cases Of Multiple Myeloma Are Expected In 2023 • Source: Shutterstock

More from Clinical Trials

More from R&D